Research and Markets: Allergic Conjunctivitis - Pipeline Review, H2 2012

Fri Jul 26, 2013 6:03am EDT

* Reuters is not responsible for the content in this press release.

Research and Markets: Allergic Conjunctivitis - Pipeline Review, H2 2012

Research and Markets ( has announced the addition of the "Allergic Conjunctivitis - Pipeline Review, H2 2012" report to their offering.

This research provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Allergic Conjunctivitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Allergic Conjunctivitis.

The data is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.


- A snapshot of the global therapeutic scenario for Allergic Conjunctivitis.

- A review of the Allergic Conjunctivitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Allergic Conjunctivitis pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

Key Topics Covered:

List of Tables

List of Figures



Allergic Conjunctivitis Overview

Therapeutics Development

An Overview of Pipeline Products for Allergic Conjunctivitis

Allergic Conjunctivitis Therapeutics under Development by Companies

Allergic Conjunctivitis Therapeutics under Investigation by Universities/Institutes

Late Stage Products

Comparative Analysis

Mid Clinical Stage Products

Comparative Analysis

Pre-Clinical Stage Products

Comparative Analysis

Allergic Conjunctivitis Therapeutics - Products under Development by Companies

Allergic Conjunctivitis Therapeutics - Products under Investigation by Universities/Institutes

Companies Involved in Allergic Conjunctivitis Therapeutics Development

Bausch & Lomb Incorporated

Allergan, Inc.

Bayer HealthCare AG

Santen Pharmaceutical Co., Ltd

Sun Pharmaceutical Industries Limited

Fovea Pharmaceuticals SA


Oxagen Limited

Morria Biopharmaceuticals Plc

Drug Profiles

Allergic Conjunctivitis Therapeutics - Drug Profile Updates

Allergic Conjunctivitis Therapeutics - Discontinued Products

Allergic Conjunctivitis Therapeutics - Dormant Products

Allergic Conjunctivitis - Product Development Milestones

Featured News & Press Releases


For more information visit

Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals